Application Study of Infusing Irritant Medications Through Midline Catheter Based on Real World Study

Last updated: January 25, 2023
Sponsor: Sir Run Run Shaw Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Catheter Complications

Treatment

N/A

Clinical Study ID

NCT05710835
IVTEAM202301
  • Ages > 14
  • All Genders

Study Summary

The goal of this observational study is to learn about the effect on midline catheter outcomes when infusing irritant medications through midline catheter. The main questions it aims to answer are:Identify the current situation of infusing irritant medications through midline catheter;Explore the effect on midline catheter outcomes when infusing irritant medications through midline catheter;Identify specific medications that affect catheter outcomes.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age ≥14 years old
  • Patients who had a midline catheter

Exclusion

Exclusion Criteria:

  • Patients who received vesicant medications through the midline catheter
  • Patients who had both a midline catheter and a central vascular access device

Study Design

Total Participants: 1500
Study Start date:
December 01, 2022
Estimated Completion Date:
June 30, 2024

Study Description

First, the patients were divided into two groups according to whether irritant medications were infused or not,then observed the rate of complications between the two groups.Second, grouped according to the irritant medications, Identify specific medications that affect catheter outcomes through statistical analysis.

Connect with a study center

  • Linfang Zhao

    Hangzhou, Zhejiang 310000
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.